Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Semaglutide Therapy for Alcohol Reduction - Tulsa

NCT05891587 is registered in ClinicalTrials.gov with Oklahoma State University Center for Health Sciences as lead sponsor.

NCT NCT05891587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05891587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Semaglutide Therapy for Alcohol Reduction - Tulsa
Lead sponsor
Oklahoma State University Center for Health Sciences
Phase
Phase 2
Overall status
Completed
Start date
July 7, 2023
Completion date
October 1, 2025
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder